US FDA lists Sun Pharma's Halol unit under 'import alert'The United States Food and Drug Administration (US FDA) has placed Sun Pharmaceuticals' Halol unit under 'import alert'. This implies that ...
US FDA issues Form 483 with 10 observations to Sun Pharma’s Halol unitListed pharmaceutical entity Sun Pharmaceutical Industries on Tuesday informed the exchanges that the US FDA has issued Form 483 with ten o...
MG Motor India to shut Halol manufacturing unit for 7 days to curb COVID-19 spread"We have decided to close our plant in Halol @Vadodra for seven days to break the chain of COVID. And our employees are committed to stay s...
Sun Pharma drops 3% as USFDA initiates action against Halol facilityUSFDA inspected the facility from December 3 to December 13 and had issued eight observations, the company had earlier said in a regulatory...
USFDA conducts inspection of Sun Pharma’s Halol site: SourcesThe USFDA inspection at Halol in 2015 had resulted in 23 observations – a set of deficiencies in the manufacturing processes.
US FDA may inspect Sun Pharma’s Halol site in February: SourcesEarlier in September 2014, the Halol site came under the lens, receiving as many as 23 observations from the US agency.The inspection culmi...
USFDA report on Halol unit to be positive in long-term: SunThe company's Halol facility recently underwent an inspection by the US Food and Drug Administration (USFDA).
Sun Pharma EPS may fall by up to 6% on USFDA notice on Halol plantThe US FDA issued the notice on Tuesday with nine inspectional observations after an onsite inspection of Sun Pharma’s Halol facility in Gu...
USFDA’s notice may shave off 2-6% from Sun Pharma's EPS in FY18Analyst believes that Form 483 observations may delay the clearance of Halol facility and see full remediation only by first quarter of cal...
USFDA made 9 observations post Halol unit inspection: Sun PharmaThe United States Food and Drug Administration (USFDA) inspected the Halol facility from November 17, 2016 through December 1, 2016, Sun Ph...
FDA issues observations post Sun Pharma Halol plant inspectionThe approval of several of Sun's key drugs in the United States, the drugmaker's biggest market, depends on the clearance on its Halol plan...
Sun Pharma shares set to extend losses for fourth day on rising concern over Halol facilityETNow on Tuesday reported that the USFDA has informed that the Halol facility has issued a 14-page Form 483 post inspection.
For Sun Pharma, a lot rides on USFDA's report on Halol PlantThe Sun Pharma stock has appreciated 13% since the announcement of its second quarter performance on November 10.
Sun Pharma Halol site being inspected by US FDA: SourcesOver its recent call with investors, Sun Pharma management had maintained that the remediation exercise at the site have been completed and...
Sun Pharma to ask FDA in Q1 FY17 for Halol re-inspectionDrug major Sun Pharmaceutical Industries may ask the US health regulator in the first quarter of next fiscal for re-inspection of its Halol...
Sun Pharma gets warning letter from US FDA for its Halol siteSun Pharmaceutical Industries today said it has received a warning letter from the USFDA over violation of manufacturing norms in its facil...
Ceat Q2 profit at Rs 77 cr; to invest Rs 650 crore on Halol plantThe company is planning to invest Rs 650 crore to expand its Halol-based manufacturing facility. Its Sri Lankan operations too apparently c...